返回
Modelling iterative compound optimisation using a self-avoiding walk
DOI:10.1016/j.drudis.2008.10.007.png)
摘要
En 中文
The optimisation phase is a crucial step in the process of drug development, yet the mechanics of the projects that make it up are poorly understood. Weak documentation of failed projects makes statistical analysis of the factors affecting project performance challenging, so a better approach may be the development of an underlying theory of how projects work. We present a model based on a modified random walk in a relevant chemical space and use it to produce simulations of projects and portfolios of projects. Simulation is used to explore parameters that might affect the performance of a project and shows that they fall into two groups - target and process - that affect the overall performance in distinct ways.
Keyword:
DRUG DEVELOPMENT
INNOVATION
QSAR
END
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
7.5
论文数:
6.4K
被引数:
2.3W
机构
暂无机构信息
引用论文
A case study of lean drug discovery: from project driven research to innovation studios and process factories
DRUG DISCOVERY TODAY
IF7.5

